Intravitreal bevacizumab for choroidal neovascularization associated with a retinochoroidal coloboma.
Rajendran
A
A
Gupta
S R
SR
Brahadeesh
S
S
Ramasamy
K
K
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002829:Choroid / Q000002:abnormalities*; D020256:Choroidal Neovascularization / Q000150:complications / Q000188:drug therapy*; D003103:Coloboma / Q000150:complications*; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D012160:Retina / Q000002:abnormalities*; D016896:Treatment Outcome; D014792:Visual Acuity
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab